Skip to main content
Version date: 28 May 2019 - onwards
Version 3 of 3

TR Question 36: OTC Derivatives Novations [last updated: 28 May 2019]

Article 9 of EMIR

Article 9 of EMIR - OTC Derivatives Novations

How should counterparties report OTC derivatives novations?

TR Answer 36

For reporting purposes, only instances where a counterparty (being a CCP or another counterparty) steps into the derivative contract and becomes a new counterparty to the derivative contract should be reported with Action Type “New”. For the original report relating to the existing derivative, counterparties should send a termination report marked as ’C= Early termination’, completing the field "Termination date". The remaining counterparty and the new counterparty should then send a new report with action type "New" relating to the new derivative.